title: First Dutch national guidelines--pharmacological care for detained opioid addicts.
abstract: Heterogenic care of addicted detainees in the various prisons in The Netherlands triggered the National Agency of Correctional Institutions of the Ministry of Justice, to order the Dutch Institute for Health Care Improvement (CBO) to formulate the first national guideline titled 'Pharmacological care for detained addicts'. This article presents the content of this guideline, which mainly focuses on opioid-dependent addicts. In The Netherlands, approximately 50% of the detainees are problematic substance abusers, while again half of this group suffers from psychiatric co-morbidity. In addition, somatic co-morbidity, especially infectious diseases, is also common. Due to the moderate outcome seen with voluntary drug counselling regimes in prison, there is a policy shift to extent utilization of legally enforced approaches. Continuity of care is of great importance. In case of opioid addicts this, in general, means continuation of methadone maintenance treatment. Aftercare immediately after detention and optimalization of medical information transfer is crucial. This guideline aims to realize optimal and uniform management of addiction disorders in the Dutch prison system.
authors.affiliation: Independer Health Care, Dutch Association of Addiction Medicine, PO Box 1632, 1200 BP Hilversum, The Netherlands. marleenarends@yahoo.com.
authors.forename: M T
authors.initials: MT
authors.lastname: Arends
authors.forename: H A
authors.initials: HA
authors.lastname: De Haan
authors.forename: G I C M
authors.initials: GI
authors.lastname: Van 't Hoff
mesh_terms: D002047:Buprenorphine / Q000008:administration & dosage / Q000627:therapeutic use; D003141:Communicable Diseases / Q000453:epidemiology*; D015897:Comorbidity; D003266:Continuity of Patient Care / Q000458:organization & administration / Q000592:standards*; D005260:Female; D006291:Health Policy; D006297:Health Services Accessibility / Q000592:standards*; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000453:epidemiology*; D008691:Methadone / Q000008:administration & dosage / Q000627:therapeutic use; D009426:Netherlands / Q000453:epidemiology; D058850:Opiate Substitution Treatment / Q000379:methods / Q000592:standards*; D009293:Opioid-Related Disorders / Q000188:drug therapy* / Q000453:epidemiology / Q000534:rehabilitation; D017410:Practice Guidelines as Topic; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy / Q000453:epidemiology; D011329:Prisoners / Q000706:statistics & numerical data*
chemical_list: D002047:Buprenorphine; D008691:Methadone
keywords: Continuity of care; Opioid‐dependent addicts; Pharmacological care